Medtronic Japan Launches Sales of Thin OmniaSecure MRI Defibrillation Lead
NQ Score
91/100
N1 Content Completeness
95
Key facts
- Medtronic Japan Launches Sales of Thin OmniaSecure MRI Defibrillation Lead
- Medtronic Japan launched the OmniaSecure MRI Lead on June 1, 2026. Featuring a thin 4.7Fr diameter, it aims to reduce complication risks like venous obstruction and is placed using a delivery catheter.
- Source: PR TIMES
- Date: Thu Jun 04 2026 10:00:03 GMT+0900 (Japan Standard Time)
Direct answer
Medtronic Japan launched the OmniaSecure MRI Lead on June 1, 2026. Featuring a thin 4.7Fr diameter, it aims to reduce complication risks like venous obstruction and is placed using a delivery catheter.
- Citation
- Medtronic Japan Launches Sales of Thin OmniaSecure MRI Defibrillation Lead (Thu Jun 04 2026 10:00:03 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Thu Jun 04 2026 10:00:03 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Medtronic Japan launched the OmniaSecure MRI Lead on June 1, 2026. Featuring a thin 4.7Fr diameter, it aims to reduce complication risks like venous obstruction and is placed using a delivery catheter.
AI Analysis
Frequently Asked Questions
- Q: What is the brand name of the defibrillation lead that Medtronic Japan launched on June 1, 2026?
- A: The brand name of the defibrillation lead launched by Medtronic Japan is OmniaSecure MRI.
- Q: On what specific date did Medtronic Japan begin sales of the OmniaSecure MRI Lead?
- A: Medtronic Japan began sales of the OmniaSecure MRI Lead on June 1, 2026.
- Q: What is the diameter size of the OmniaSecure MRI Lead introduced by Medtronic Japan?
- A: The OmniaSecure MRI Lead has a thin diameter of 4.7Fr introduced by Medtronic Japan.
- Q: Which company launched the OmniaSecure MRI Lead in Japan on June 1, 2026?
- A: Medtronic Japan launched the OmniaSecure MRI Lead in Japan on June 1, 2026.
- Q: What medical benefit does the 4.7Fr OmniaSecure MRI Lead from Medtronic Japan provide?
- A: The 4.7Fr OmniaSecure MRI Lead helps reduce risks of complications such as venous obstruction.